Regeneron Pharmaceuticals, Inc.
Synaptojanin 2 (SYNJ2) Variants And Uses Thereof

Abstract:

The present disclosure provides methods of treating patients having hearing loss, methods of identifying subjects having an increased risk of developing hearing loss, methods of detecting human Synaptojanin-2 (SYNJ2) variant nucleic acid molecules and variant polypeptides, and SYNJ2 variant nucleic acid molecules and variant polypeptides.